HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study ...Middle East

Medscape - News
HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study
According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African participants who bear the highest burden of HIV-1. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study )

Apple Storegoogle play

Also on site :